See more : HUTCHMED (China) Limited (HCM.L) Income Statement Analysis – Financial Results
Complete financial analysis of Sang-A Frontec Co.,Ltd. (089980.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sang-A Frontec Co.,Ltd., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
- Public Joint Stock Company RBC (RBCM.ME) Income Statement Analysis – Financial Results
- Manning Ventures Inc. (MANN.CN) Income Statement Analysis – Financial Results
- CAVE Interactive CO.,LTD. (3760.T) Income Statement Analysis – Financial Results
- Univa Foods Limited (UNIVAFOODS.NS) Income Statement Analysis – Financial Results
- Stamper Oil & Gas Corp. (STMGF) Income Statement Analysis – Financial Results
Sang-A Frontec Co.,Ltd. (089980.KQ)
About Sang-A Frontec Co.,Ltd.
Sang-A Frontec Co.,Ltd. engages in the research and development, production, and sale of materials/parts based on engineering plastics in South Korea and internationally. The company offers fuel cells; membranes, including vent filters and ePTFE for textiles, as well as membranes for medical use; semiconductor products, such as jar boxes, solar cassettes, FOUP products, wafer carriers, storage boxes, PFA/FEP tubes, and mold release films; medium and large, cylindrical, and small type batteries; and display products comprising cell cassettes, ACF bonding sheets, support bars, and FPD cassettes. It also provides automotive products consisting of air vents, and PTFE tubes and rings; OA products that include wireless charging kits, laser printer/MFP/copy machines, metal sleeves, fuser films, fuser and transfer belts, and guide claws; SG and LX sheet, and backup board PCBs; and medical devices, such as safety filter syringes, epidural needle kits, Green Medi green VACs, and filter needle syringes. The company was founded in 1974 and is headquartered in Incheon, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 183.60B | 181.16B | 178.48B | 153.35B | 186.17B | 182.07B | 153.24B | 156.29B |
| Cost of Revenue | 147.42B | 141.70B | 142.03B | 123.83B | 148.56B | 144.30B | 121.30B | 123.99B |
| Gross Profit | 36.18B | 39.45B | 36.45B | 29.51B | 37.61B | 37.78B | 31.94B | 32.30B |
| Gross Profit Ratio | 19.70% | 21.78% | 20.42% | 19.25% | 20.20% | 20.75% | 20.84% | 20.67% |
| Research & Development | 7.22B | 8.21B | 7.00B | 6.47B | 6.44B | 7.95B | 6.63B | 6.43B |
| General & Administrative | 2.38B | 1.94B | 1.73B | 1.83B | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 4.08B | 3.99B | 4.43B | 4.38B | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.46B | 17.78B | 16.73B | 15.06B | 15.55B | 15.12B | 13.93B | 16.12B |
| Other Expenses | 13.54B | -550.69M | -759.42M | -603.16M | -728.35M | -587.41M | -605.64M | -699.88M |
| Operating Expenses | 27.22B | 26.54B | 24.49B | 22.13B | 22.72B | 23.66B | 21.17B | 23.25B |
| Cost & Expenses | 174.65B | 168.25B | 166.52B | 145.96B | 171.29B | 167.96B | 142.46B | 147.24B |
| Interest Income | 2.40B | 1.32B | 1.25B | 1.27B | 1.09B | 639.82M | 542.70M | 179.61M |
| Interest Expense | 7.43B | 5.81B | 5.57B | 3.14B | 2.66B | 1.93B | 1.94B | 1.55B |
| Depreciation & Amortization | 13.58B | 12.72B | 10.63B | 9.40B | 9.22B | 9.07B | 8.61B | 7.84B |
| EBITDA | 37.92B | 25.64B | 22.58B | 19.66B | 24.11B | 26.67B | 19.38B | 16.89B |
| EBITDA Ratio | 20.65% | 14.15% | 12.65% | 10.95% | 12.95% | 12.74% | 12.65% | 10.81% |
| Operating Income | 8.96B | 12.91B | 11.96B | 7.38B | 14.89B | 14.12B | 10.77B | 9.05B |
| Operating Income Ratio | 4.88% | 7.13% | 6.70% | 4.82% | 8.00% | 7.75% | 7.03% | 5.79% |
| Total Other Income/Expenses | 8.05B | -4.05B | -1.16B | -260.44M | -722.88M | 1.54B | -1.30B | -40.78M |
| Income Before Tax | 17.00B | 8.85B | 10.81B | 7.12B | 14.16B | 15.66B | 9.47B | 9.01B |
| Income Before Tax Ratio | 9.26% | 4.89% | 6.05% | 4.65% | 7.61% | 8.60% | 6.18% | 5.77% |
| Income Tax Expense | 5.01B | 1.43B | 1.51B | 4.80B | 1.71B | 3.60B | 2.00B | 3.54B |
| Net Income | 11.99B | 7.43B | 9.30B | 2.32B | 12.45B | 12.06B | 7.47B | 5.47B |
| Net Income Ratio | 6.53% | 4.10% | 5.21% | 1.51% | 6.69% | 6.63% | 4.87% | 3.50% |
| EPS | 769.00 | 476.30 | 607.81 | 152.93 | 841.77 | 853.55 | 549.59 | 418.52 |
| EPS Diluted | 769.32 | 476.30 | 607.81 | 151.50 | 798.59 | 773.57 | 528.25 | 400.75 |
| Weighted Avg Shares Out | 15.60M | 15.59M | 15.30M | 15.17M | 14.79M | 14.13M | 13.59M | 13.06M |
| Weighted Avg Shares Out (Dil) | 15.59M | 15.59M | 15.30M | 15.31M | 15.59M | 15.59M | 14.14M | 13.64M |
Source: https://incomestatements.info
Category: Stock Reports